MedPath

Efficacy of Bupropion on sexual function of women with orgasmic disorder

Phase 3
Recruiting
Conditions
Orgasmic disorder.
Female orgasmic disorder
F52.31
Registration Number
IRCT20090801002266N9
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

Reading and writing literacy
Woman aged 18 to 50 years
Negative pregnancy test and no action for pregnancy during the intervention
Having a sexual partner (husband) who has no sexual dysfunction (spouse sexual intercourse is rejected by clinical interview).
She is in a marital relationship for at least six months, not considering divorce or separation, and alternately having sex with her husband.
The lack of active psychiatric illness Not having sexual desire and pain disorder (disparonius and vaginismus) simultaneously
Non-menopause (natural or surgical)
Not having a history of primary and secondary infertility The complaint of a global female orgasmic disorder should be as follows: a) Frequency of orgasms during sexual intercourse in less than 50% of sexual relationships. b) There is a disorder for at least 6 months. c) Has reached orgasm at least 3 times in the last 6 months.
Not having anxiety disorder at the same time (Beck anxiety disorder score less than 10).
Not having depressive disorder at the same time (Beck Depression Questionnaire score is less than 10).
Not having sexual and paraphilia disorders
History of seizure or head injury
No substance abuse or alcohol abuse over the past year
Non-use of psychiatric drugs and any drugs that affect sexual function (chronic use of opioids beta blockers, alpha-adrenergic drugs, psychotropic drugs)
Failure to receive synchronous psychological intervention

Exclusion Criteria

Dissatisfaction to continue participating in the study at any time
Pregnancy during the study
Couple's death or divorce during the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in female sexual function score base on the female sexual function index. Timepoint: Before intervention 2, 4, 6, 8 weeks after intervention. Method of measurement: Female sex function index questionnaire.;Changes in female sexual satisfaction. Timepoint: Before intervention 2, 4, 6, 8 weeks after intervention. Method of measurement: Larsson Women's Sexual Satisfaction Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath